Physician

Timothy Pearson, M.D.

According to 2025 Medicare claims, Timothy Pearson, M.D. (NPI: 1972845121) practices dermatology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is SKIN SURGERY CENTER PA (NPI: 1649237082; TIN: 562205718) and primary practice location at 28374-9864.

Pearson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,634 traditional Medicare patients, billed 9,475 HCPCS/CPT codes, and received $337,980 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,514 prescription claims across 635 beneficiaries totaling $1,209,515 in drug costs, led by Cosentyx Sensoready Pen (Secukinumab). Open Payments data shows 31 records totaling $670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $54,532 to $337,980. Similarly, Part D prescription costs have moved sharply higher in recent years, from $265,381 to $1,209,515. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$205K$411K2017 Medicare payment: $54,532 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $253,650 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $346,026 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $369,715 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $388,631 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $389,404 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $410,693 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $337,980 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172911,351$54,532
20181,0485,759$253,650
20191,4267,705$346,026
20201,6768,222$369,715
20211,9779,219$388,631
20221,4789,511$389,404
20231,55510,036$410,693
20241,6349,475$337,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$605K$1.2M2015 Drug cost: $265,381 (USD; Tot_Drug_Cst)2016 Drug cost: $181,041 (USD; Tot_Drug_Cst)2017 Drug cost: $41,561 (USD; Tot_Drug_Cst)2018 Drug cost: $69,308 (USD; Tot_Drug_Cst)2019 Drug cost: $170,855 (USD; Tot_Drug_Cst)2020 Drug cost: $374,853 (USD; Tot_Drug_Cst)2021 Drug cost: $452,227 (USD; Tot_Drug_Cst)2022 Drug cost: $601,720 (USD; Tot_Drug_Cst)2023 Drug cost: $711,544 (USD; Tot_Drug_Cst)2024 Drug cost: $1,209,515 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015136387$265,381
2016153412$181,041
2017211484$41,561
2018282695$69,308
2019383983$170,855
20204421,102$374,853
20215961,343$452,227
20225271,181$601,720
20236391,502$711,544
20246351,514$1,209,515

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth465542$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2101,730$56
17000Destruction of precancer skin growth, 1 growth8401,168$36
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more206225$35
17003Destruction of precancer skin growth, 2-14 growths6844,040$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready PenSecukinumab11308$162,269
Humira(Cf) PenAdalimumab14392$99,824
Dupixent PenDupilumab24644$89,413
Dupixent SyringeDupilumab14392$52,308
FluorouracilFluorouracil1133,101$6,631

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$670ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Timothy Pearson, M.D.?

Tedicare shows public-source Medicare data for Timothy Pearson, M.D. (NPI 1972845121), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Pearson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Timothy Pearson, M.D.?

Timothy Pearson, M.D. is linked to SKIN SURGERY CENTER PA (billing NPI 1649237082) in the available physician profile data.

Does Timothy Pearson, M.D. have Open Payments data?

Timothy Pearson, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.